Published in Circ Res on November 01, 1984
Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs (1990) 1.43
The cardiorenal syndrome: lessons from the ADHERE database and treatment options. Heart Fail Rev (2004) 1.27
Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest (1993) 1.00
"Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy. J Clin Invest (1988) 0.97
Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest (1992) 0.96
Chronic kidney disease and cardiovascular complications. Heart Fail Rev (2015) 0.95
Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormone. Drugs (1986) 0.94
Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion. J Clin Invest (1985) 0.92
Renal artery blood flow velocity in very low birthweight infants with intrauterine growth retardation. Arch Dis Child (1993) 0.89
Loss of tubuloglomerular feedback in decompensated liver cirrhosis: physiopathological implications. Dig Dis Sci (2005) 0.84
Effects of angiotensin-converting enzyme inhibition on altered renal hemodynamics induced by low protein diet in the rat. J Clin Invest (1987) 0.80
The renin angiotensin aldosterone system and frusemide response in congestive heart failure. Br J Clin Pharmacol (1995) 0.78
Inhibition of soluble epoxide hydrolase does not improve the course of congestive heart failure and the development of renal dysfunction in rats with volume overload induced by aorto-caval fistula. Physiol Res (2015) 0.77
Imaging of cardiac and renal perfusion in a rat model with 13N-NH 3 micro-PET. Int J Cardiovasc Imaging (2014) 0.75
AVP-induced increase in AQP2 and p-AQP2 is blunted in heart failure during cardiac remodeling and is associated with decreased AT1R abundance in rat kidney. PLoS One (2015) 0.75
Effect of angiotensin converting enzyme inhibitor on collagen production by cultured mesangial cells. Korean J Intern Med (1994) 0.75
A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure. Br J Clin Pharmacol (1991) 0.75
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data. PLoS One (2016) 0.75
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med (1995) 4.94
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
Myocardial infarct size and ventricular function in rats. Circ Res (1979) 4.33
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1999) 3.90
A comparison of management patterns after acute myocardial infarction in Canada and the United States. The SAVE investigators. N Engl J Med (1993) 3.75
The relationship between peritubular capillary protein concentration and fluid reabsorption by the renal proximal tubule. J Clin Invest (1969) 3.39
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial. Lancet (2000) 3.39
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators. Circulation (1999) 3.26
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med (1982) 3.13
Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med (1997) 3.13
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature (1995) 3.06
Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest (1985) 2.99
Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest (1986) 2.96
Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest (1986) 2.91
Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation (1994) 2.74
Increased pulse pressure and risk of heart failure in the elderly. JAMA (1999) 2.74
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators. N Engl J Med (1992) 2.72
The progression of renal disease. N Engl J Med (1988) 2.70
Nephron adaptation to renal injury or ablation. Am J Physiol (1985) 2.65
Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation (1997) 2.64
Molecular basis of proteinuria of glomerular origin. N Engl J Med (1978) 2.61
Dynamics of glomerular ultrafiltration in the rat. IV. Determination of the ultrafiltration coefficient. J Clin Invest (1973) 2.55
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation (2000) 2.47
Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest (2000) 2.42
Progressive ventricular remodeling in rat with myocardial infarction. Am J Physiol (1991) 2.40
Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int (1981) 2.36
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Diabetologia (2010) 2.35
A model of glomerular ultrafiltration in the rat. Am J Physiol (1972) 2.32
Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest (1985) 2.32
The dynamics of glomerular ultrafiltration in the rat. J Clin Invest (1971) 2.27
The relationship between glomerular filtration rate and sodium reabsorption by the proximal tubule of the rat nephron. J Clin Invest (1968) 2.27
Dynamics of glomerular ultrafiltration in the rat. II. Plasma-flow dependence of GFR. Am J Physiol (1972) 2.24
Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res (1985) 2.23
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med (1998) 2.22
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation (1986) 2.22
Primary structure and functional expression of a cDNA encoding the thiazide-sensitive, electroneutral sodium-chloride cotransporter. Proc Natl Acad Sci U S A (1993) 2.15
Effects of some vasodilator drugs on transcapillary fluid exchange in renal cortex. Am J Physiol (1976) 2.01
Influence of postglomerular hematocrit and protein concentration on rat nephron fluid transfer. Am J Physiol (1971) 1.97
Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest (1991) 1.96
Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation (1985) 1.92
Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest (1998) 1.90
Determination of serum protein concentration in nanoliter blood samples using fluorescamine or 9-phthalaldehyde. Anal Biochem (1978) 1.89
Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int (1982) 1.86
Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A (1985) 1.85
Isolated systolic hypertension : prognostic information provided by pulse pressure. Hypertension (1999) 1.83
Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. Kidney Int (1975) 1.83
Predicting initiation and progression of chronic kidney disease: Developing renal risk scores. Kidney Int (2006) 1.80
Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry. Eur Heart J (1999) 1.76
Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int (2000) 1.74
Relationship between extracellular volume and fluid reabsorption by the rat nephron. Am J Physiol (1969) 1.74
ROMK inwardly rectifying ATP-sensitive K+ channel. II. Cloning and distribution of alternative forms. Am J Physiol (1995) 1.72
Intrachromosomal genomic instability in human sporadic colorectal cancer measured by genome-wide allelotyping and inter-(simple sequence repeat) PCR. Cancer Res (2001) 1.69
Effects of norepinephrine and angiotensin II on the determinants of glomerular ultrafiltration and proximal tubule fluid reabsorption in the rat. Circ Res (1975) 1.69
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial. J Am Coll Cardiol (1998) 1.67
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation (1994) 1.67
Role of aldosterone in the remnant kidney model in the rat. J Clin Invest (1996) 1.65
Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int (1983) 1.65
An inhibitory effect of furosemide on sodium reabsorption by the proximal tubule of the rat nephron. J Clin Invest (1969) 1.65
Permselectivity of the glomerular capillary wall to macromolecules. II. Experimental studies in rats using neutral dextran. Biophys J (1975) 1.64
Dynamics of glomerular ultrafiltration in the rat. 3. Hemodynamics and autoregulation. Am J Physiol (1972) 1.63
How they begin and how they end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol (1999) 1.63
Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial. Circulation (1998) 1.63
Dynamics of glomerular ultrafiltration in the rat. VII. Response to reduced renal mass. Am J Physiol (1974) 1.62
Mechanisms of action of various hormones and vasoactive substances on glomerular ultrafiltration in the rat. Kidney Int (1981) 1.62
Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. J Clin Invest (1983) 1.60
Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol (1999) 1.56
Downloadable computer models for renal replacement therapy. Kidney Int (2006) 1.56
Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function. Circ Res (1981) 1.55
Micropuncture study of nephron function in the rhesus monkey. J Clin Invest (1968) 1.55
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest (1984) 1.55
Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell (1999) 1.54
Permselectivity of the glomerular capillary wall. Facilitated filtration of circulating polycations. J Clin Invest (1978) 1.53
Cost-effectiveness of captopril therapy after myocardial infarction. J Am Coll Cardiol (1995) 1.52
Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med (1971) 1.51
Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med (1986) 1.50
Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol (1992) 1.50